实用医学杂志 ›› 2021, Vol. 37 ›› Issue (4): 542-546.doi: 10.3969/j.issn.1006⁃5725.2021.04.025

• 综述 • 上一篇    下一篇

Ⅳ型心肾综合征发病机制研究新进展

姚超逸, 张义德   

  1. 1 南通大学医学院(江苏南通 226001);2 南通大学附属医院(江苏南通 226001

  • 出版日期:2021-02-25 发布日期:2021-02-25
  • 通讯作者: 张义德 E⁃mail:myzhangyi2001@163.com
  • 基金资助:
    国家自然科学基金面上项目(编号:81670699)

New progress in the pathogenesis of type IV cardiorenal syndrome

YAO Chaoyi,ZHANG Yide
  

  1. School of Medicine,Nantong University,Nantong 226001,China
  • Online:2021-02-25 Published:2021-02-25
  • Contact: ZHANG Yide E⁃mail:myzhangyi2001@163.com

摘要:

Ⅳ型心肾综合征对于慢性肾脏病患者的死亡率和预后具有重要的影响。但目前对于Ⅳ 心肾综合征发病机制的了解还不全面,治疗手段还不能有效控制型心肾综合征对慢性肾脏病患者生命的威胁。因此还需要对型心肾综合征的发病机制进一步深入研究,以开发出新的有效治疗手段。本文将近年重点关注的型心肾综合征发病机制的新进展做一综述,以期为药物研发提供依据,并指导临床诊断和治疗。

关键词:

Abstract:

Type Ⅳ cardiorenal syndrome plays an important role in the mortality and prognosis of patients with chronic kidney disease(CKD). At present,the understanding of the pathogenesis of type Ⅳ cardiorenal syndrome is not comprehensive,and current treatment methods cannot effectively control the life threat of type Ⅳ cardiorenal syndrome to CKD patients. Therefore,it is necessary to further explore the pathogenesis of type Ⅳ cardiorenal syndrome and develop new effective therapy methods. This article attempts to review the recent progress in the pathogenesis of type Ⅳ cardiorenal syndrome,which might provide the basis for medicine design and guide clinical diagnosis and treatment.

Key words: